Polytestosterone phloretin phosphate
androgen and anabolic steroid
Polytestosterone phloretin phosphate (PTPP) is an androgen and anabolic steroid as well as androgen ester which was never marketed. It is an ester of testosterone with phosphoric acid that is in the form of a polymer and is coupled with phloretin. Like other androgen esters, PTPP acts as a long-lasting prodrug of testosterone in the body. However, analogously to the polymeric estrogen esters polyestradiol phosphate (PEP), polyestriol phosphate (PE3P), and polydiethylstilbestrol phosphate (PSP), PTPP has a strongly prolonged duration with very uniform testosterone levels in animals compared to non-polymeric testosterone esters. According to its developers, this is "exactly the effect which should be aimed at in order to approach natural hormone production as closely as possible". PTPP was developed around 1953 at the same time as PEP and its patent was published in 1960. The patent was assigned to the Swedish pharmaceutical company Leo Läkemedel AB, which also developed PEP.
PEP is a linear polymer of on average 13 repeat units of estradiol phosphate. Each individual estradiol unit in the molecule is connected by its C3 and C17β hydroxyl groups to phosphoric acid linkers that are present between the estradiol moieties. In contrast to estradiol, such a polymer is not possible with testosterone because testosterone has only one hydroxyl group and hence does not have the two hydroxyl groups necessary for linking the testosterone units together. In PTPP, phloretin is used as a coupling agent to solve this problem and create a testosterone phosphate polymer.
The public source identifies “Polytestosterone phloretin phosphate” as androgen and anabolic steroid. This brief keeps that definition visible, then builds a research path around Polytestosterone, phloretin and phosphate.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Polytestosterone phloretin phosphate”, the useful work is to connect “androgen and anabolic steroid” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jan 27, 2026. The linked authority identifier is Q48810447. The first chronological checks are 1953 and 1960.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Polytestosterone phloretin phosphate”, its source revision and the description used here.
- Expand the search: follow Polytestosterone phloretin phosphate primary sources, Polytestosterone phloretin phosphate archive and Polytestosterone research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Polytestosterone phloretin phosphate”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Polytestosterone phloretin phosphate” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.